AXGN Q3 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$60M+23.5% YoY

Gross Profit

$46M76.6% margin

Operating Income

$2M3.2% margin

Net Income

$708,0001.2% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$216M

Total Liabilities

$96M

Stockholders' Equity

$121M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$49M	+23.5%
Gross Profit	$46M	$36M	+26.2%
Operating Income	$2M	-$316,000	+705.1%
Net Income	$708,000	-$2M	+138.1%